UK reg­u­la­tor se­lects tiny Mass­a­chu­setts biotech's po­ten­tial Gauch­er gene ther­a­py for ac­cel­er­at­ed path­way

The UK’s Med­i­cines and Health­care prod­ucts Reg­u­la­to­ry Agency is in­creas­ing­ly grant­i­ng drug­mak­ers ac­cess to its ex­clu­sive In­no­v­a­tive Li­cens­ing and Ac­cess Path­way, with Cam­bridge, MA-based Avro­bio …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER